However, prostate cancers often relapse and progress to a stage termed as castration-resistant prostate cancers (CRPC) (67, 68), and the majority of these CRPCs still depend on the AR signaling for growth and progression (the AR addictiveness) (69, 70). Here, AR is linked to prostate carcinoma.